1 The pharmacology of ATP responses and the expression pattern of seven known subunits of the P2X receptor were investigated in individual histaminergic neurons of the tuberomamillary nucleus (TM). 2 ATP (3 ± 1000 mM) evoked fast non-desensitizing inward currents in TM neurons. 2-methylthioATP (2MeSATP) displayed the same ecacy but a lower potency, EC 50 s 84 mM versus 48 mM, when compared with ATP. Adenosine-diphosphate (ADP), uridine-triphosphate (UTP) and alpha beta methylene-ATP (ab-meATP) were inactive. 3 ATP-mediated whole cell currents were potentiated by acidi®cation of the recording solution (pH 7.5 and 6.6 were compared). 4 Single-cell RT ± PCR (scRT ± PCR) analysis revealed that the P2X 2 receptor is expressed in all PCR-positive neurons. Each of the P2X 1 , P2X 3 , P2X 4 , P2X 5 and P2X 6 mRNAs were detected in less than 35% of the cells. 5 Suramin antagonized ATP responses with an IC 50 of 4.2 mM and pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS, 1 mM) reduced ATP responses to 43% of control, when antagonists were pre-applied 90s before the agonist. Cibacron blue (3 mM) given together with ATP potentiated control responses by 67%, but inhibited it to 10% after pre-application. 6 2',3'-O-(2,4,6-Trinitrophenyl) adenosine 5'-triphosphate (TNP ± ATP) antagonized ATP responses with an IC 50 of 7 mM. 7 Pharmacological properties of ATP responses together with scRT ± PCR data suggest that P2X 2 is the major purinoceptor on the soma of TM neurons, however the presence of heteromeric P2X 2/5 receptors in some neurons cannot be excluded.
Introduction
ATP is found in every cell, where it is a major source of energy. In the nervous system, ATP has additional actions, which include its role in fast synaptic transmission and modulation (North & Surprenant, 2000; Khakh et al., 2001) . Activity of histaminergic cells in the tuberomamillary nucleus (TM) of the posterior hypothalamus is closely associated with behavioural state (Lin et al., 1988) : they ®re tonically during waking, little during slow wave sleep, and not at all during rapid-eye-movement (REM) sleep. As homeostatic theory of sleep involves ATP depletion and adenosine accumulation in the brain (Huston et al., 1996; Benington & Heller, 1995; Arrigoni et al., 2001 ) the role of ATP-and adenosine-receptors in the main sleep-controlling centres needs to be elucidated. The tuberomamillary nucleus receives inputs from the pre-frontal cortex, the preoptic area, and the septum-diagonal band. Its eerents reach most parts of the brain (Watanabe et al., 1984; Schwartz et al., 1991; Wada et al., 1991) , providing, together with other aminergic systems the waking-drive in the brain (Brown et al., 2001) . High levels of purinoceptor proteins (Loesch & Burnstock, 2001; Collo et al., 1996) and mRNA expression (Kanjhan et al., 1999) in tuberomamillary neurons are in keeping with ATP-induced rapid inward currents in these neurons (Furukawa et al., 1994) . ATP is coreleased with dierent neurotransmitters (Mori et al., 2001; Nakatsuka & Gu, 2001; Jo & Role, 2002) and can enhance transmitter release through the presynaptic P2X and P2Y receptors (Jang et al., 2001; Norenberg & Illes, gic neurons using speci®c purinoceptor antagonists and single-cell RT ± PCR.
Methods

Animals and cell preparation
Housing of rats and all procedures were carried out in accordance with the Animal Protection Law of the Federal Republic of Germany. All eorts were made to minimize animal suering or discomfort and to reduce the number of animals used. After decapitation of 3 ± 4-week-old male Wistar rats (n=20) the brain was quickly removed and 450 mm thick transverse slices containing the TM region were cut (1 or 2 slices per rat) and incubated for 1 h in a solution containing (mM): NaCl 125, KCl 3.7, CaCl 2 1.0, MgCl 2 1.0, NaH 2 PO 4 1.3, NaHCO 3 23, D-glucose 10, phenol red 0.01%, bubbled with carbogen (pH 7.4). For preparation of isolated cells the lateral part of the TM nucleus was dissected from the slice and incubated with papain in crude form (0.3 ± 0.5 mg ml
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) for 40 min at 378C. After rinsing the tissue was placed in a small volume of recording solution with the following composition (in mM): NaCl 150, KCl 3.7, CaCl 2 2.0, MgCl 2 2.0, HEPES 10, pH adjusted to 7.4 with NaOH. Cells were separated by gentle pipetting. The selected cells were digitally photographed on an inverted microscope and their major axes measured. After whole-cell recording the cytoplasm was sucked into the electrode and cell identi®ca-tion was veri®ed by RT ± PCR analysis of histidine decarboxylase (HDC) expression.
Whole-cell current recording
Membrane currents were recorded using the standard wholecell con®guration of the patch-clamp technique. Micropipettes were fabricated from ®lament-containing thick-wall borosilicate glass tubes using a two-stage puller and had resistances between 2 and 5 MOhm after ®lling with the following solution adjusted to pH 7.3 (in mM): 140 CsCl, 2 MgCl 2 , 0.5 CaCl 2 , 5 EGTA, 10 HEPES/CsOH. The cells were voltage-clamped by an EPC-9 ampli®er. After establishment of the whole cell con®guration the series resistance (4 ± 15 MO) was compensated (70 ± 90%) and periodically monitored. The holding potential was 755 mV. Data were collected with commercially available software (TIDA for Windows, HEKA, Lambrecht, Germany).
Drug application
A fast perfusion technique was used for application of purinoreceptor agonists (Vorobjev et al., 1996) . An isolated cell was ®rst patch clamped and then lifted into the application system, where it was continuously perfused with control bath solution. The substances were applied through two glass capillaries, 0.2 mm in diameter. Three solutions owed continuously, gravity-driven, at the same speed and fast lateral movements of the capillaries exposed a cell either to control-or test-solutions. The system allows brief exposures to agonists alone or in combination with antagonists. Solution exchange at the open tip of a patch electrode developed with a time constant of 0.5 ms or less.
Data analysis
Agonists concentration-response relationships were ®tted with the equation (1) 
Cellular RNA harvest and reverse transcription
After recording, the cytoplasm of the cell was sucked into the electrode in a stream of sterile control solution. The content of the electrode (8 ml solution with cell) was expelled into an Eppendorf tube, containing 7 ml of a mixture prepared according to the protocol of the`®rst strand cDNA synthesis kit' (Pharmacia Biotech, Freiburg, Germany). After incubation for 1 h at 378C for reverse transcription (RT) this reaction was stopped by freezing at 7208C. PCR analysis was carried out to identify TM neurons and to determine the presence of P2X-receptor types. The primer sequences are listed in Table 1 . Primers designed to recognize HDC cDNA were previously published (Sergeeva et al., 2001) , the expected size of the ampli®cation product was 457 base pairs. Thin-walled PCR tubes contained a mixture of ®rst strand cDNA template (2 ± 5 ml), 106 PCR buer (5 ml), 10 pM each of sense and antisense primer, 200 mM of each dNTP and 2.5 units Taq polymerase. The ®nal reaction volume was adjusted to 50 ml with nuclease-free water (Promega, Mannheim, Germany). The magnesium concentration was 2.5 mM in all ampli®cations. The Taq enzyme, PCR buer, Mg 2+ solution, and four dNTPs were all purchased from Qiagen (Erkrath, Germany). All oligonucleotides were synthesized by MWG-Biotech (Ebersberg, Germany). Ampli®cation was performed on a thermal cycler (Perkin Elmer, GeneAmp 9600, Weiterstadt, Germany). A two round ampli®cation strategy was used in each protocol. In each round 35 cycles of the following thermal programs were used: denaturation at 948C for 48 s, annealing at 508C for 48 s, and extension at 728C for 1 min. For the second ampli®cation round 1 ml of the product of the ®rst PCR was used as a template.
Products were visualized by staining with ethidium bromide and analysed by electrophoresis in 2% agarose gels. Representative products were puri®ed (PCR puri®cation kit from Qiagen, Erkrath, Germany) in water and sequenced in both directions on an automatic sequencing machine (ABI, model 377, Weiterstadt, Germany). They were found to match the published sequences (see Table 1 ). Care was taken to ensure that the PCR signal arose from the single-cell mRNA. Three negative controls were taken in every experiment: (i) electrode solution was expelled in reaction tube as a template for the RT ± PCR after submerging of electrode in the recording chamber with isolated neurons but no cell clamped or sucked in; (ii) to ensure that genomic DNA did not contribute to the PCR products, neurons were aspirated and processed in the same manner except that the reverse transcription was omitted; (iii) contamination from extraneous sources was checked by replacing the cellular template with water.
Drugs and chemicals
Adenosine 5'-triphosphate disodium salt (ATP), adenosine 5'-diphosphate potassium salt (ADP), 2-methylthioadenosine 5'-triphosphate tetrasodium salt (2MeSATP), a,b-methyleneadenosine 5'-triphosphate lithium salt (ab-meATP), cibacron blue, suramin sodium salt, pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid tetrasodium salt (PPADS), 2',3'-O-(2,4,6-Trinitrophenyl)Adenosine 5'-Triphosphate (TNP-ATP), uridine-5'-triphosphate (UTP) sodium salt and gamino-n-butyric acid (GABA) obtained from Sigma/RBI (Deisenhofen, Germany).
Results
ATP-mediated currents in identified TM neurons
All neurons isolated from the ventral TM (n=69) responded to ATP (range from 3 mM to 1 mM) with fast nondesensitizing inward currents, indicating the presence of P2X purinoceptors. Maximal current amplitudes evoked by ATP at a saturating concentration (1 mM) were 0.5+0.06 nA (n=69, range 0.05 to 2.3 nA), much smaller than the amplitudes of GABA (500 mM) responses (1 to 26% of the GABA response, 9.0+1.15% (n=31) on average).
Single cell RT ± PCR and whole-cell recordings
We combined whole-cell recordings with the single-cell RT ± PCR (scRT ± PCR) analysis of P2X receptor expression. Total mRNA, isolated from the TM nucleus was used as a positive control in RT ± PCR analysis. We detected all seven known P2X receptors in this brain region ( Figure 1A ). Doseresponse relations for ATP and the expression pattern of P2X receptors (scRT ± PCR) were investigated in 34 neurons. Antagonism by suramin, TNP ± ATP and PPADS were tested in some of these cells. A total of 33 were HDC (histidine decarboxylase) -positive, indicating that the majority of isolated neurons were histaminergic. They varied in soma size (16 ± 30 mm) and shape (polygonal or round). One or more types of P2X receptors were detected in 17 neurons 
Pharmacology of ATP-mediated responses
Recombinant homomeric P2X (1 ± 7) receptors have dierent anity to agonists (Khakh et al., 2001) . The potent agonist at homomeric recombinant P2X 1 , P2X 3 and heteromeric P2X 2/3 purinoceptors alpha beta-methylene-ATP (ab-meATP) at 300 mM did not evoke any current in TM neurons (n=3). The P2 receptor agonist 2-methylthioATP (2MeSATP) demonstrated the same ecacy but a slightly lower potency (EC 50 ) when compared with ATP in the same cells (Figure 2 ). When dose-response relations for the ATP and 2MeSATP obtained in seven neurons were ®tted with the equation (1), the following EC 50 and Hill coecient values were obtained: 47.6+1.7 mM, 1.6+0.07 and 83.85+6.96 mM, 1.45+0.15, respectively. Adenosine-diphosphate (ADP, 1 mM, n=3) and uridine-triphosphate (UTP, 2 mM, n=3) did not evoke a current in TM neurons.
Can protons modulate ATP-responses? Acidi®cation of the recording solution (pH 6.6 instead 7.5 in control conditions) potentiated ATP (30 mM) responses by 179+29% (n=5, Figure 2B ).
Our scRT ± PCR analysis revealed that the majority of the TM neurons expressed more than one P2X receptor-type. Are these dierent P2X receptor sub-populations (P2X 2 , P2X 2/3 , P2X 4 , P2X 1/5 , P2X 6 , P2X 2/5 ) functionally present at the somata of TM neurons? In order to answer this question we tested several known P2X receptor-type-speci®c antagonists. Suramin inhibited ATP (100 mM) responses in a dosedependent manner. When suramin was given during an ATP application, it inhibited agonist-responses with an IC 50 =27.7+2.1 mM (nHill=1.19+0.1, n=3, Figure 3 ). When suramin in several dierent concentrations was pre-applied Amplitude of ATP (100 mM, % of control response) in the presence of suramin (5 mM). Antagonist was pre-applied for 90 s. n.m. ± not measured. for 90 s before ATP (100 mM), the dose-response relation yielded an IC 50 =4.2+0.3 mM and a Hill coecient= 1.6+0.15 (n=8).
Pyridoxalphosphate -6 -azophenyl -2',4' -disulphonic acid (PPADS), given during an ATP (100 mM) application slightly reduced the response (to 85+5%, n=3) at a concentration of 300 mM ( Figure 4A ). PPADS inhibited ATP-evoked currents with much higher potency when it was applied for 1 ± 160 s before the agonist. The longer the pre-application time, the more pronounced was the block. When the resulting ATP response amplitudes were plotted versus time of PPADS preapplication, data points could be ®tted with an exponential function, yielding the following time constants and relative amplitudes of responses at maximal inhibition: t=40+7 s, 0.34+0.03 (n=3), t=20+1 s, 0.06+0.01 (n=4) and t=3+0.1 s, 0.02+0.06 (n=3) for the 1, 3 and 100 mM of PPADS respectively ( Figure 4B, C) . In order to test cell-tocell variability in their sensitivity to PPADS we perfused 1 mM of this blocker for 90 s prior to the common ATP/ PPADS application. All tested neurons were PPADSsensitive, the average inhibition was to 43.4+3.3% of control (n=9). Complete recovery of control responses was not observed after prolonged PPADS administration. After a 5 min washout period the ATP responses reached 60+3.2% of the control response (n=9).
Cibacron blue when given during ATP (30 mM) application at 3 mM potentiated the response by 67+0.12% (n=4), but inhibited it at 100 and 300 mM to 9+4% and 3.5+3%, respectively (n=4, Figure 5A ). When cibacron blue was preapplied for 40 s it inhibited ATP (30 mM) responses to 10+2% (n=3) and to 3+1.5% (n=2) at 3 and 30 mM, respectively.
In order to test the functional presence of P2X 2/3 receptors we used TNP ± ATP (2',3'-O-(2,4,6-Trinitrophenyl)Adenosine 5'-Triphosphate (Virginio et al., 1998; Burgard et al., 2000) to block ATP (100 mM) responses. As a 90 s pre-application did not change the extent of block, co-application was used in this experiment. When the dose-response curve was ®tted with equation (2) we obtained an IC 50 =7.1+0.5 mM and a Hill coecient n=1.77+0.22 (n=5, Figure 6 ).
Discussion
We used a combination of single cell RT ± PCR and patchclamp electrophysiology to identify the P2X receptors in rat histaminergic neurons. TM neurons responded to ATP and 2MeSATP with a rapid non-desensitizing inward current and did not respond to UTP consistent with the activation of P2X channels. UTP is a weak or inactive agonist at P2X receptors, but an agonist at several P2Y receptors (Ralevic & Burnstock, 1998) . ADP and alpha beta methylene-ATP (abmeATP) did not induce any current in TM neurons. When compared with maximal GABA-currents, the maximal ATP responses represented only a small fraction (9%). We have shown previously (Sergeeva et al., 2002) that gabazine (10 mM) completely blocks spontaneous IPSCs in TM neurons, which is dierent from lateral hypothalamic neurons, where residual spontaneous currents were found to be ATP-mediated (Jo & Role, 2002) . Failure to detect such currents in TM neurons may be related to a smaller ATP/ GABA amplitude ratio. Physiological activation of P2X receptors in TM neurons needs to be elucidated in the future.
TM neurons responded to exogenously applied ATP with an EC 50 =50 mM, in keeping with previously reported values for non-identi®ed acutely isolated neurons from the TM region (EC 50 =44 mM) (Furukawa et al., 1994) and for the PC12 cells (EC 50 =45 mM) (Michel et al., 1996) . Recombinant homomeric P2X 1 and P2X 3 and heteromeric P2X 2/3 , P2X 1/5 and P2X 4/6 receptors display much higher ATP sensitivity (EC 50 =1 ± 6 mM), while heteromeric P2X 2/6 receptors give EC 50 values (30 mM) (Khakh et al., 2001 ) similar to our study. We did not ®nd a correlation between ATP EC 50 s and the expression pattern of dierent P2X receptors in TM neurons. The reason for this ®nding may be the absence of functional P2X 1 and P2X 3 receptors in the somata of TM neurons, which is also evident from the lack of sensitivity to ab-meATP and the low sensitivity of ATP-responses to TNP ± ATP (7 mM in our study). TNP ± ATP is much more potent at P2X 1 , P2X 3 and P2X 2/3 receptors (EC 50 s are 6, 1 and 7 nM, respectively), than at other subtypes with P2X 4 being most insensitive (EC 50 =15 mM) (North & Surprenant, 2000) .
Several groups have reported that 2-methylthioATP (2MeSATP) is a partial agonist and much less potent than ATP in activating P2X 4 receptors (Soto et al., 1996; Wang et al., 1996; Jones et al., 2000) . In TM neurons 2MeSATP demonstrated the same ecacy and a slightly lower potency than ATP (corresponding EC 50 s were 84 mM versus 48 mM). In all neurons tested ATP responses were completely blocked by suramin (20 mM) and PPADS (100 mM), while heterologously expressed P2X 4 and P2X 6 receptors were insensitive or only slightly aected by blockers taken in concentration of 100 mM (reviewed in Khakh et al. (2001) and Norenberg & Illes, (2000) ). Therefore, we can exclude the formation of functional homomeric P2X 4 or P2X 6 receptors on the somata of TM neurons. The presence of P2X 4/6 heteromers is also unlikely, these two receptors were never co-expressed in single TM neurons, see Table 2 . Recombinant P2X 2 , P2X 1 and P2X 3 receptors are more sensitive to pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS, IC 50 =1 mM), than other P2X subtypes, with P2X 4 being the most insensitive (4300 mM) (North & Surprenant, 2000) . In TM neurons 1 mM of PPADS caused half inhibition of ATP responses, when pre-application was used. Heterologously expressed P2X 1 , P2X 2 , P2X 3 and P2X 5 receptors are sensitive to suramin, with half-maximal inhibition at concentrations of 1 to 5 mM (Khakh et al., 2001) ). Suramin, when applied before ATP, caused half inhibition of control responses in our study (4 mM), which indicates, together with the other pharmacological properties of ATP responses found in TM neurons, the functional presence of P2X 2 receptors.
P2X 2 receptors show potentiation of ATP responses under acidi®cation of the extracellular solution, as a result of the increased anity of the channel for ATP in the presence of protons (Ding & Sachs, 1999; King et al., 1997) . In contrast, P2X 1 , P2X 3 , P2X 4 receptors are inhibited by lowering pH (Stoop et al., 1997) . In TM neurons ATP responses were dramatically potentiated by an increase in proton concentration (pH 6.6 versus pH 7.5 in control solution).
The inhibition pro®le by cibacron blue (an isomer of reactive blue 2) of ATP responses in TM neurons is hard to interpret, as no detailed studies are available on this subject. The eects of cibacron blue on P2X 4 receptors appear complex. A recent study has shown that cibacron blue, when co-applied with ATP, is a weak antagonist at the rat P2X 4 receptor (IC 50 4300 mM) while P2X 4 currents are enhanced by pre-incubation with low concentrations of cibacron blue (3 ± 30 mM) (Miller et al., 1998) . The rat P2X 4 receptor has been shown in another study to be half inhibited at approximately 120 mM of cibacron blue in rats (Soto et al., 1996) . We cannot exclude the functional presence of P2X 2/5 receptors on the somata of some TM neurons as a formation of this heteromer is possible (Torres et al., 1999) and its pharmacological features are not known.
Our molecular and pharmacological data show that P2X 2 is the predominant receptor type in rat histaminergic neurons and provide a useful basis for elucidating its physiological relevance.
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